Alzheimer's disease (AD) is the most common form of dementia. Even with its well-known symptoms of memory loss and well-characterized pathology of beta amyloid (A) plaques and neuro¯brillary tangles, the disease pathogenesis and initiating factors are still not well understood. To tackle this problem, a systems biology model has been developed and used to study the varying e®ects of variations in the ApoE allele present, as well as the e®ects of short term and periodic in°ammation at low to moderate levels. Simulations showed a late onset peak of A in the ApoE4 case that lead to localized neuron loss which could be ameliorated in part by application of short-term pro-in°ammatory mediators. The model that has been developed herein represents one of the¯rst attempts to model AD from a systems approach to study physiologically relevant parameters that may prove useful to physicians in the future.
Introduction
Alzheimer's disease (AD) is the most common cause of dementia in the elderly. It begins as the loss of short term memory and proceeds with the loss of long term memory as the disease progresses. Other symptoms of the disease include cognitive decline, depression, loss of voluntary muscle control and labile mood. At the histological level, AD pathology has been characterized by the presence of gross A plaques and neuro¯brillary tangles of hyperphosphorylated tau protein. 1 With the increased size of the aged population in the Western world, the incidence of AD is expected to rise signi¯cantly in the next 30 years. A variety of cellular changes have been observed in AD. The most prominent change is elevated A levels, which forms the basis of the amyloid cascade hypothesis. The oligomeric form of A has been shown to be neurotoxic and suppress long term potentiation (LTP) necessary to form memories. 2, 3 Neuroin°ammation has also been suggested to play a key role in the pathogenesis of the disease, however its role has not been determined as of yet. A connection between these two hypotheses does exist: A has been shown to induce production of the pro-in°ammatory cytokines interleukin-1 (IL-1) and TNF, which stimulates further production of A and creates a positive feedback loop until the A is cleared. 4, 5 Prolonged high levels of neuroin°ammation have been shown to lead to synaptic dysfunction and neuronal loss, though low to moderate levels of pro-in°ammatory cytokines can actually help ameliorate the levels of A by increasing the clearance rate. 4 In°ammation is also balanced by the delayed production of interleukin-6 (IL-6) by microglia, which inhibits the generation of IL-1 and TNF.
Dysregulation of lipid metabolism has also been suggested to play a role in AD pathogenesis. 6, 7 Of particular importance is apolipoprotein E (ApoE), an apoprotein responsible for transporting cholesterol within the plasma, as well as from astrocytes to neurons within the brain. 6 ApoE has three alleles ("2, "3, "4) that are commonly found in individuals, with the "4 allele being associated with a signi¯cantly increased risk of late-onset AD. It is the only prevalent genetic risk factor for AD other than the recently identi¯ed TREM2 variants. 8 Mitochondrial dysfunction with subsequent collapse of ATP levels and release of glutamate leading to production of reactive oxygen species (ROS) and cellular necrosis has been observed in AD. 9 Prolonged elevations of glutamate are also known to trigger release of cytochrome c from the mitochondrial membrane and trigger apoptosis. 9 The N-methyl D-aspartate (NMDA) receptor is known to play an important role in this process and has been implicated as a common convergent pathway for many other neurodegenerative disorders, including Parkinson's disease and Huntingdon's disease. Beta amyloid is also known to have an inhibitory e®ect on complex IV of the electron transport chain and pyruvate dehydrogenase (PDH), thus decreasing ATP levels.
Given the variety of complex mechanisms that may possibly be at play in the pathogenesis of AD can be an overwhelming task from the experimental biology standpoint. Mathematical modeling helps to de¯ne these interactions in more logical terms and allows for varying interactions in ways that are not easily possible using experimental techniques. By taking a systems biology approach, the model presented here builds on a model that we have previously developed, with important adaptations to study the role of the ApoE genotype on disease progress, and how genotype a®ects the response to in°ammatory stimuli. Both cellular number and relative concentration of important chemical species has been modeled. Cellular number is a dynamic process that changes in response to environmental and chemical triggers.
This represents one of the¯rst systems biology models available to study AD pathogenesis.
Beta amyloid processing
Beta amyloid (A) is derived from the proteolytic processing of the amyloid precursor protein (APP) found on neuronal cell membranes and, to a lesser extent, on vesicular membranes. Cleavage of APP by -secretase (BACE), subsequently followed by -secretase cleavage, results in the formation of A. Cleavage by -secretase leads to alternative, nonneurotoxic products.
Beta amyloid processing has been shown to be a®ected by the density of cholesterol in the plasma membrane, as well as the local in°ammatory state. Experimental data has been mixed as to whether cholesterol levels in lipid rafts promote or inhibit A cleavage. 6, 10, 11 In this model, we have assumed that excess serum cholesterol and low total brain cholesterol are positive risk factors for AD most related to the ApoE allele present. 12, 13 The "4 allele signi¯cantly decreases the ability of cholesterol and A to interact with their respective receptors. In the brain, this leads to decreased neuronal cholesterol in addition to a decreased ability to clear A from the brain via the blood-brain barrier (BBB). Additionally, experimental studies in an AD mouse model that we performed demonstrated that decreasing cholesterol through application of a statin lead to increased A. 12 
Cholesterol & ApoE
Cholesterol is an extremely important molecule within the brain and serves important functions in synapse formation and maintenance, as a component of lipid rafts, in maintaining membrane stability, and in the synthesis of steroid-derived molecules such as cortisol. Dysregulation of cholesterol metabolism within the brain is associated with neuron loss and cognitive de¯cits. 6, 14, 15 The majority of cholesterol is found within the plasma membrane and has a high a±nity for associating with membranes containing sphingolipids and saturated phospholipids. 6 There are two known methods of cholesterol transport: vesicular and nonvesicular. Vesicular transport requires an intact cytoskeleton (microtubule tracts) and ATP to utilize motor proteins such as kinesin and dynein. Nonvesicular transport occurs via transport proteins such as ApoE. Within the brain, astrocytes are responsible for synthesizing the majority of cholesterol utilized by neurons, thus the nonvesicular pathway is believed to be the dominant method of cholesterol transport.
ApoE has three common variants depending on the single nucleotide polymorphism (SNP) present as de¯ned above as ApoE "2, "3, "4. 16 Studies have determined that the general allelic frequency varies with the population, with a frequency range of 6.4-10.1%, 61-78.3%, and 14.5-26.6% for "2, "3, "4, respectively. 10 The majority of individuals are homozygous for "3, with the next largest groups being "3="4 and "2="3. 10 Patients with the "4 allele are at a signi¯cantly increased risk of getting AD, while patients with the "3 allele have average risk and those with the "2 allele are slightly protected from AD. This may be due to the di®erent binding capacities of the ApoE alleles; ApoE binds A with an a±nity of "2 > "3 > "4. 6 Tighter binding may allow A to be more e®ectively cleared from the brain. These frequencies were taken into account during the simulation of this model.
Neuroin°ammation
In°ammation has been a well-known process in AD and was even noted by Alois Alzheimer during his study of the disease that would carry his name. It is not well understood whether the in°ammation is a result of the A pathology, causes the A pathology or works synergistically with A to lead to the pathological state that is observed in AD. Experimental data has shown that the innate immune response is involved in the pathologic cascade via the following mechanism: A stimulates the innate immune response via CD14 and Toll-like receptors (TLRs). 17 This in turn stimulates the production of pro-in°ammatory cytokines such as IL-1 and TNF. 5 Low levels of IL-1 have been shown to have a neuroprotective role via stimulation of A clearance by activated microglia. 5 Genetic association studies have demonstrated that individuals with AD have an increased in°ammatory response to the presence of A. 5 This response increases each time the patient is exposed to elevated levels of A, which may precipitate an ampli¯ed and potentially neurotoxic in°ammatory response.
Model De¯nition
In this model, a two level hierarchy of network interaction was developed. At the cellular level, the four main cell types (neurons, astrocytes, microglia, and brain endothelial cells) were allowed to interact with each other (Fig. 1) . At the molecular level, each of these cell types had their own metabolic network that generated molecules related to their speci¯c cellular function. For example, neurons are the main source for A, which was modeled as neurons generating A from APP cleavage. The products of the biochemical network of each cell type are then allowed to interact with the molecular products of other cellular networks in a process that allows modeling at the cellular and molecular levels.
The number of each type of cell was initialized ( Table 1 ). The chemical species of each cell type was modeled by the average distribution and adjusted based on the number of cells of that type present. This method was chosen over modeling individual cells since it would be computationally di±cult to model neural tissue at this level of detail given the sheer number of cells involved (on the order of millions of cells, even if looking at a relatively small volume of brain tissue). Additionally, this level of detail is unnecessary to model the general trends that would be seen by the interaction of these networks.
This model studied the interactions between several key parameters: A generation, mitochondrial function, in°ammation, and ApoE genotype. Rate constants and initialization values for key molecules are listed in Table 1 . Model equations are discussed in further detail in the following paragraphs and the corresponding interaction in the network graph corresponds to the equation number.
Model equations
The following paragraphs describe in detail the equations and methods that were used to model the above network. The network described here was simpli¯ed to represent only the most relevant nodes of the overall pathway. Glucose levels are directly proportional to pyruvate levels given that the reaction has a relatively large ÀÁG with several irreversible phosphorylation events driving the reaction forward. Pyruvate is transformed to acetyl coenzyme A (acetyl CoA) via the action of PDH, an enzyme that has been shown to be inhibited by beta amyloid. 18 The equation is written as amount produced per neuron and modi¯ed accordingly:
The network branches from acetyl coenzyme A to include paths to the citric acid cycle (TCA), the malonyl coenzyme A pathway (fatty acid metabolism) and to acetylcholine generation in neurons (an important neurotransmitter). In astrocytes, it also branches to cholesterol generation via the mevalonate pathway. TCA is the major source of cellular ATP, producing 12 ATPs per acetyl CoA molecule. The conversion of pyruvate to acetyl CoA produces an additional three ATP molecules per pyruvate. Complex IV of the electron transport chain is inhibited by elevated beta amyloid levels, 18 and is incorporated as an inhibitor of ATP generation (denoted by r 6 ):
where r 6 is the inhibition of ATP generation by A. The amount of A generated per time step was dependent on the number of neurons present and a stochastic cleavage rate of APP: where r 1 describes the repression of A production by cholesterol, a 1 is a function of the IL1 concentration (increased IL1 stimulates increased production of A), U is a uniform distribution with mean 0.0015 and represents the stochastic generation of A from di®erential interaction of the secretases with APP, and k is the degradation rate constant and is dependent on the expression level of LRP-1 on brain endothelial cells. As discussed in the introduction, cholesterol generation occurs mainly by astrocytes in the adult brain. Cholesterol production proceeds from HmgCoA through the mevalonate pathway through a highly energy intensive process. Elevated levels of cholesterol inhibit the action of HmgCoA reductase, preventing the conversion of HmgCoA to mevalonate. Cholesterol transport to neurons is dependent on the levels of the ApoE and LRP proteins. 19 ApoE carries cholesterol from astrocytes to neurons, while the low density lipoprotein-related protein (LRP) transports cholesterol into neurons. 6, 7, 11 Interestingly, LRP is also responsible for the majority of transport of A e®lux from the brain. 20 This relationship has been modeled here by the following two equations, depending on whether ApoE or LRP is the dominant molecule:
The innate immune response is the primary in°ammatory response within the brain, 5 and is modeled by describing the levels of IL-1, TNF and IL-6 with respect to each other and to the level of beta amyloid. TNF is produced predominantly by activated microglia and its e®ects are dependent on the concentration that it is expressed at. Low concentrations (< 10 À9 M) of TNF lead to local in°ammation, stimulation of integrin expression by brain endothelial cells that leads to increased transmigration of leukocytes across the BBB, and stimulation of endothelial cells and microglia to produce chemokines and cytokines, such as IL-1. 5 At increased concentrations, TNF acts on the hypothalamus, leading to the synthesis of prostaglandins and subsequently fever. Systemic increases in TNF may lead to hypoglycemia and thus intracellular ATP levels. This has been represented by the following equation, where g 2 represents the production of TNF by brain endothelial cells and microglia, respectively:
Interleukin-1 (IL-1) is produced by activated microglia, astrocytes, and brain endothelial cells. Like TNF, increased levels of IL-1 upregulate integrin expression by brain endothelial cells and subsequently increases transmigration of monocytes into the brain with di®erentiation into microglia. 4 ,5 IL-6 is known to inhibit the secretion of both IL-1 and TNF, and has been included as a repressor in this model (r 5 ):
where g 1 and g 2 describe the production of IL1 by endothelial cells and microglia, respectively; g 3 describes the generation of IL6 by microglia; and r 5 describes the inhibitory function that IL6 has on IL1 generation. Glutamate neurotoxicity is another important component of the neuroin-°a mmatory response present in AD. Elevated levels of glutamate are generated in response to cell injury, which in turn increases the intracellular levels of calcium via NMDA receptors. Elevated intracellular calcium levels stimulate oxidative phosphorylation, triggering the production of ROS that eventually lead to cell death. 9 Glutamate concentration levels were modeled by two cases:
if ATP levels has decreased below a pre-de¯ned threshold (5% of normal levels, which would happen within 1 min of loss of glucose/blood°ow or ischemia from other sources). If ATP levels were normal or returned to normal after a stimulus, glutamate levels would exponentially decay:
Programming & simulation environment
The model was coded and simulated using Matlab. The simulation was run for 10,000 time steps, where each time step represents a single day. Nodes were updated with each step with respect to changes in connected nodes as de¯ned by the above equations. Feedback was included in the model to account for conservation of mass and internal feedback loops that are known to exist within these networks. Molecular number was initialized as described in Table 1 . Cell number changed in response to the combined e®ects of ATP levels, A levels and local concentration of proin°ammatory cytokines above a speci¯ed level. Simulations were run to study the e®ects of the three ApoE variants on overall disease progression, and then expanded to study how short term and periodic in°ammation a®ect this progression.
Model robustness
The robustness of the model was veri¯ed by varying the A transfer rate constant (ae 2 ) from 0.1 to 0.35 and studying what happened to the A and neuronal ATP levels. Simulations showed similar results up to ae 2 ¼ 0:35, which was the expected transition point to the ApoE4 allelic variation (Fig. 2 ).
Results

Reference simulation
The initial simulation that was run studied the system response for a patient homozygous for ApoE3, the most common ApoE allelic variation in the general population (Fig. 3) . Cell number and molecular distribution was consistent with what was expected for this ApoE variant. Beta amyloid varied stochastically which gave rise to variations in the neuronal ATP levels that mirrored these changes (due to the inhibitory e®ects of A on ATP generation).
E®ect of ApoE allele
As stated previously, the ApoE allele contributes signi¯cantly to the rate of A clearance across the BBB via the LRP-1 receptor. This e®ect on the progression of the disease was studied by varying the rate at which A deposited in brain endothelial cells and contributed to the observed vascular A load (Fig. 4) . ApoE2/4 and ApoE3/4 alleles had quantitatively similar results.
E®ect of short-term, pulsed in°ammation
The e®ect of short-term in°ammation was studied to determine if there was any alteration to disease pathogenesis when a pro-in°ammatory state was simulated. A single, signi¯cantly elevated pulse of pro-in°ammatory molecules (IL1, TNF) was applied for a duration of 50 time steps (equivalent of 50 days) to model the e®ects of short term in°ammation (Fig. 5) .
E®ect of periodic in°ammation
Periodic elevations of pro-in°ammatory molecules (IL1, TNF) were modeled to study the interaction between ApoE allele and the sensitivity of the system to an in°ammatory response [recall that biological experiments have shown that carriers of (a) Fig. 4 . E®ect of ApoE alleles on disease pathogenesis. (a) ApoE3/3 homozygote is the reference simulation and demonstrates that there is no change in neuron number or beta amyloid (on average) over the course of the simulation. (b) ApoE2/4 heterozygote, demonstrates that an unsustainable peak in A that occurs late in the disease process that leads to complete loss of neurons in the localized region that is modeled. (c) ApoE2/3 heterozygote demonstrates that the qualitative results are similar between the ApoE 3 homozygote and heterozygote and is sustainable over the course of time. (d) ApoE4/4 homozygote. This is the most severe case that is possible and is evident by the fact that neuronal cell death occurs earlier than the heterozygote case. the ApoE4 allele are more sensitive to the in°ammatory response (Fig. 6) ]. The single high strength in°ammatory pulse modeled in Sec. 3.3 was followed by two very short in°ammatory pulses. These pulses can biologically represent anumber of possible conditions a®ecting patients, such as meningitis, traumatic brain injury, major depressive episode, or other neuroinfection, all of which elevate the pro-in°ammatory markers for a short duration.
E®ect of chronic, low level in°ammation
TNF is produced by microglia in response to in°ammatory stimuli such as A and has been suggested to be a nonspeci¯c marker of AD. As discussed before, low levels of TNF stimulate the transmigration of leukocytes across the BBB, increasing the number of activated microglia present in the neural tissue to¯ght o® infections or remove foreign material. Chronic low levels of TNF were modeled to study whether there was a di®erence in response depending on the ApoE allele, as well as determine the strength of the in°ammatory response in driving AD pathology (Fig. 7) . The model allows for the transmigration of leukocytes and subsequent di®erentiation into microglia, temporarily increasing the number of microglia within the modeled brain region. 
Discussion
In this paper, we have presented the results of several simulations run with the network model that we have developed. The system models the interactions between key molecules in in°ammation, lipid metabolism, energy production, and A production at both the molecular and cellular levels. The reference simulation demonstrated a stable network that is able to generate A and ATP at stochastic rates (as de¯ned by the model), while also modeling changes in the cellular microenvironment. Late onset increase in the innate immune system was modeled by increasing the transient number of microglia within the brain region being studied, as demonstrated by the slight increase in microglia number.
Simulations studying the e®ect of di®erent ApoE alleles on the progression of disease demonstrated that having even one ApoE4 allele eventually lead to a signi¯cant local increase in A that lead to the collapse of ATP levels and subsequent elevation of glutamate as is seen in experimental data. This was unsustainable, and led to the loss of all neurons in that local region over the course of an equivalent 1 to 1.5 years. This relatively abrupt loss of neurons was not ideal to model the neuronal loss actually seen in AD that often takes years to decades to develop such signi¯cant losses, and needs to be adapted in future models to better study this rate of neuronal loss. It is interesting to note that the collapse in ATP levels and loss of neurons was a late event in the simulations that was dependent on the allelic state of ApoE. ApoE4 heterozygotes fared better than ApoE4 homozygotes, but inevitably met the same fate. Qualitatively, this corresponds to the more severe risk for AD in those patients who are homozygous for ApoE4, with an increased AD risk in heterozygote patients.
Simulations on the e®ect of short-term in°ammation showed that the level of neuronal cholesterol increased nearly immediately in response to the in°ammatory response, regardless of the ApoE genotype, before returning to baseline levels. The elevated cholesterol levels suppress cleavage of APP into A during this period, which subsequently eliminates the variability of neuronal ATP levels (this variability is a function of A levels since A inhibits PDH and thus ATP generation). Following this suppression of variability, ATP levels started to decrease slowly, which lead to a slow increase in A. Eventually, this triggered glutamate toxicity that led to the collapse of ATP levels, followed by neuronal cell death. ApoE4 homozygotes appeared to bene¯t from this short in°ammatory pulse by delaying the neuronal cell loss, while ApoE2 and 3 homozygotes appeared to be harmed in the long-term by the in°ammatory pulse. This may seem a bit contradictory at¯rst, but does make sense with known experimental data. The elevated cholesterol levels during the in°ammatory pulse help to decrease the concentration of A during this period, thus decreasing the amount of A that will deposit in the brain parenchyma and at the BBB. This, in e®ect, delays the loss of neurons in those individuals with 1 or 2 ApoE4 alleles. In the case of individuals with ApoE 2 or 3, the delayed decreased levels of ATP due to the in°ammatory pulse leads to a downward spiral of increased A that at some point cannot be compensated for by degradation by microglia or clearance by LRP-1. This in turn leads to collapse of ATP generation, glutamate toxicity, and neuronal loss.
Periodic in°ammation as modeled by 3 peaks in IL-1 and TNF showed a similar phenomenon as a single in°ammatory peak, only shifting the time of neuronal cell loss early in the simulation period. The¯rst peak, modeled as 50 time steps of in°ammation (equivalent to 50 days of severe neuroin°ammation) led to an increase in neuronal cholesterol levels similar to that seen in the short-term in°ammatory simulation, however, subsequent, single day in°ammatory peaks were unable to increase cholesterol levels and suppress A generation. This suggests that in°am-mation may play a role in the AD process, but that the duration of the in°ammation, as well as the strength of the in°ammation, are important in determining whether the pro-in°ammatory state will contribute, lessen or not even a®ect A generation and AD progression.
Chronic, low level in°ammation was modeled by elevating the level of TNF for the duration of the simulation past a pre-assigned time point (in this case, for n > ¼ 5000). At this level, TNF increased the rate of leukocyte transmigration and di®erentiation into microglia, stimulating the initial increase in IL-1. This increase in IL-1 triggers IL-6 production, which has an anti-in°ammatory e®ect and decreases the number of activated microglia and amount of IL-1 and TNF. The initial prolonged increase in IL-1 also triggers an increase in the cleavage of A, and it is this increase in A that drives a return to the increased levels of IL-1, as well as inhibits PDH, decreasing the amount of Acetyl CoA that can be driven into the TCA and subsequently generate ATP. This collapse of mitochondrial function triggers the release of glutamate and, in combination with other pro-in°ammatory markers, leads to neuronal cell death. In this simulation, the ApoE allele played little role in the¯nal outcome; in all simulations, there was a collapse of ATP levels and loss of neurons. This agrees with biological data that has shown the brain is particularly sensitive to chronic in°ammation and has little recourse to protect itself from a chronic assault.
Conclusion
In conclusion, we have presented a mathematical model to study the progression of networks involved in AD pathogenesis. The key cell types are able to interact at both a cellular and molecular level, with the network describing each cell type producing the functions and chemical species that are speci¯c to that cell type. The roles of in°ammation and the ApoE genotype were also studied, and demonstrated several important concepts, including the concept that a single in°ammatory pulse in the brains of those carrying the ApoE4 allele may help protect against early neuronal cell death seen clinically by elevating cholesterol levels and e®ectively suppressing A generation during the duration of the stimulus. This same in°ammatory stimulus proves detrimental, however, if one instead carries the ApoE2 or 3 allele (without heterozygosity for ApoE4). Results of simulations with periodic in°ammation suggested that an in°ammatory pulse needed to be su±ciently long enough to produce the cholesterol spike needed to suppress A, demonstrating that the duration of in°ammation may be more important than the acute degree of in°ammation. This would be followed up on by studying the e®ect of chronic in°ammation which again showed that the duration of in°ammation was more signi¯cant than the ApoE genotype in causing elevated A levels and subsequent neuronal cell loss.
There are still many adaptations and additional terms that need to be studied to develop a model fully capable of modeling the complex behaviors that occur in AD, however, this represents the¯rst such attempt to create a multi-level network model of AD. In the future, such a model would o®er a powerful complement to experimental research, and may o®er physicians in the future the capability to better predict outcomes given speci¯ed lab values as inputs. Future work will continue to re¯ne the model and include additional, relevant terms as more clinical data becomes available, as well as expand on the role of in°ammation and ApoE allele on disease pathogenesis.
